Less frequent dosing of GLP-1 receptor agonists as a viable weight maintenance strategy
Semaglutide should not be taken if you have any of the following conditions: Personal or family history of Medullary Thyroid Carcinoma (MTC) History of Multiple Endocrine Neoplasia, type 2 (MEN2) Previous allergic reactions to Semaglutide or Tirzepatide Diabetic retinopathy Pregnancy, breastfeeding, or trying to become pregnant Under 18 years of age Depression with a history of suicidal thoughts History of pancreatitis Kidney disease or insufficiency Stomach issues that could worsen with treatment Diabetes (consult your primary care physician or endocrinologist for insurance coverage options) Program Requirements & Structure Lab Work Required : A Basic Metabolic Panel (BMP), Lipid Panel, HgA1C, and fasting insulin are needed
Specific diabetes conditions: Such as Type 1 Diabetes, a history of Diabetic Ketoacidosis (DKA), or Diabetic Retinopathy
While preclinical or earlier-stage trials in selected populations might still explore the potential of GLP-1 receptor agonists in neurodegeneration, these results serve as a reality check
What is the best form of glutathione for skin
